Blueprint Medicines Corp (NASDAQ:BPMC)

100.17
Delayed Data
As of Oct 21
 -2.30 / -2.24%
Today’s Change
43.29
Today|||52-Week Range
105.50
+25.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues11.4M27.8M21.4M44.5M
 
 
 
 
 
Depreciation And Amortization948.0K1.6M1.6M4.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses62.1M98.8M171.1M287.3M
 
 
 
 
 
Research And Development48.6M81.1M144.7M243.6M
 
 
 
 
 
Total Operating Expenses63.0M100.3M172.7M291.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-51.6M-72.6M-151.2M-247.0M
 
 
 
 
 
Extraordinary Charge-445.0K0.000.000.00
 
 
Interest Expense On Debt696.0K469.0K221.0K73.0K
 
 
 
 
 
Other Expenses16.0K551.0K3.3M10.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-52.8M-72.5M-148.1M-236.6M
 
 
 
 
 
Preferred Dividend-3.2M0.000.000.00
 
 
Net Income-52.8M-72.5M-148.1M-236.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.2M27.5M37.8M43.9M
 
 
 
 
 
Shares To Calculate EPS Diluted18.2M27.5M37.8M43.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.07-$2.64-$3.92-$5.39
 
 
 
 
 
EPS Diluted-$3.07-$2.64-$3.92-$5.39